Next Article in Journal
Lignocellulolytic Enzyme Production from Wood Rot Fungi Collected in Chiapas, Mexico, and Their Growth on Lignocellulosic Material
Next Article in Special Issue
Histoplasmosis Diagnosed in Europe and Israel: A Case Report and Systematic Review of the Literature from 2005 to 2020
Previous Article in Journal
Potential of Antifungal Proteins (AFPs) to Control Penicillium Postharvest Fruit Decay
Previous Article in Special Issue
Treatment and Prevention of Histoplasmosis in Adults Living with HIV

Paediatric Histoplasmosis 2000–2019: A Review of 83 Cases

Aberdeen Fungal Group, Institute of Medical Sciences, University of Aberdeen, Aberdeen AB25 2ZD, UK
MRC Centre for Medical Mycology, University of Exeter, Geoffrey Pope Building, Stocker Road, Exeter 4EX 4QD, UK
Author to whom correspondence should be addressed.
Academic Editors: Nathan C. Bahr and Mathieu Nacher
J. Fungi 2021, 7(6), 448;
Received: 14 May 2021 / Revised: 31 May 2021 / Accepted: 1 June 2021 / Published: 4 June 2021
(This article belongs to the Special Issue Histoplasma and Histoplasmosis 2020)
Histoplasmosis is an endemic fungal infection that is confined to specific geographical regions. Histoplasma spp. are primary pathogens that cause disease in both immunocompetent and immunocompromised patients, ranging from a single-organ (mostly affecting the lungs) infection to life-threatening disseminated disease. Knowledge about the clinical epidemiology relies on data from adult populations; little is known about the patient and disease characteristics in the paediatric population. Therefore, a structured review of published cases of paediatric histoplasmosis between 2000 and 2019 was performed. A literature search of PubMed was conducted and the epidemiological and clinical data from 83 cases were analysed. The mean age at presentation was 9.5 ± 5.5 years, and 51% were girls. Two-thirds of the children were immunocompromised. The majority of children presented with disseminated disease. The most frequently observed clinical symptoms were respiratory symptoms, alongside non-specific systemic features, including fever, myalgia, fatigue and weight loss. The mortality rate was 11%. Histoplasmosis affects children of any age. Being immunocompromised is a risk factor for severe and disseminated disease. The lack of specific presenting features leads to underreporting and delay in diagnosis. To improve the recognition and outcome of histoplasmosis in childhood, increased awareness and surveillance systems are warranted. View Full-Text
Keywords: histoplasmosis; disseminated disease; children; infants; treatment; Histoplasma spp. histoplasmosis; disseminated disease; children; infants; treatment; Histoplasma spp.
Show Figures

Figure 1

MDPI and ACS Style

MacInnes, R.; Warris, A. Paediatric Histoplasmosis 2000–2019: A Review of 83 Cases. J. Fungi 2021, 7, 448.

AMA Style

MacInnes R, Warris A. Paediatric Histoplasmosis 2000–2019: A Review of 83 Cases. Journal of Fungi. 2021; 7(6):448.

Chicago/Turabian Style

MacInnes, Rebecca, and Adilia Warris. 2021. "Paediatric Histoplasmosis 2000–2019: A Review of 83 Cases" Journal of Fungi 7, no. 6: 448.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop